Please use this identifier to cite or link to this item:
|Title:||Elimination of mother-to-child transmission of HIV - Thailand|
CDC Thailand/Southeast Asia Regional Office
Thailand Ministry of Public Health
Thai Red Cross AIDS Research Centre
National Health Security Office
|Keywords:||Environmental Science;Health Professions|
|Citation:||Morbidity and Mortality Weekly Report. Vol.65, No.22 (2016), 562-566|
|Abstract:||© 2016, Department of Health and Human Services. All rights reserved. Thailand experienced a generalized human immunodeficiency virus (HIV) epidemic during the 1990s. HIV prevalence among pregnant women was 2.0% and the mother-to-child transmission (MTCT) rate was >20% (1-3). In June 2016, Thailand became the first country in Asia to validate the elimination of MTCT by meeting World Health Organization (WHO) targets. Because Thailand’s experience implementing a successful prevention of MTCT program might be instructive for other countries, Thailand’s prevention of MTCT interventions, outcomes, factors that contributed to success, and challenges that remain were reviewed. Thailand’s national prevention of MTCT program has evolved with prevention science from national implementation of short course zidovudine (AZT) in 2000 to lifelong highly active antiretroviral therapy regardless of CD4 count (WHO option B+) in 2014 (1). By 2015, HIV prevalence among pregnant women had decreased to 0.6% and the MTCT rate to 1.9% (the elimination of MTCT target is <2% for nonbreastfeeding populations) (4). A strong public health infrastructure, committed political leadership, government funding, engagement of multiple partners, and a robust monitoring system allowed Thailand to achieve this important public health milestone.|
|Appears in Collections:||Scopus 2016-2017|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.